# Strategic Feedback — GPT-5.4 (R2)

**Role:** Journal editor (AER perspective)
**Model:** openai/gpt-5.4
**Timestamp:** 2026-03-23T10:40:23.574291
**Route:** OpenRouter + LaTeX
**Tokens:** 8685 in / 3703 out
**Response SHA256:** 3eb9f9d0484d90c4

---

## 1. THE ELEVATOR PITCH

This paper asks whether paid sick leave mandates make workplaces safer by reducing “presenteeism” — workers showing up sick and getting injured. Using staggered adoption of state sick-leave laws and OSHA injury records, it finds little evidence that mandates reduce workplace injuries in the large establishments observed in the data.

A busy economist should care because the paper targets a widely invoked but weakly tested policy claim: that paid sick leave improves not just health and labor-market outcomes, but also workplace safety. If true, that would broaden the welfare case for mandates; if false, it narrows the relevant margin.

**Does the paper itself articulate this pitch clearly in the first two paragraphs?**  
Mostly, but not sharply enough. The current opening does a decent job setting up the policy issue and the cross-sectional claim, but it takes too long to get to the actual world-level question and does not foreground the key limitation soon enough: the paper is really about the effect of mandates in the part of the labor market covered by OSHA ITA, which is disproportionately large firms. Right now the introduction overstates the generality of the question and understates the sample-bound nature of the answer.

**What the first two paragraphs should say instead:**

> Paid sick leave mandates are often justified on the grounds that they let sick workers stay home, reducing “presenteeism” and thereby preventing workplace injuries. That claim is plausible and widely cited, but the existing evidence is largely cross-sectional: workplaces that offer paid sick leave may simply also be safer for many other reasons. The central question is therefore causal and policy-relevant: when states require paid sick leave, do workplace injury rates actually fall?
>
> This paper studies that question using staggered state paid sick leave mandates and OSHA injury records covering large U.S. establishments from 2017–2023. I find no detectable reduction in injury rates following adoption of these mandates. The result suggests that, at least among larger firms that are already more likely to offer sick leave, mandates do not generate meaningful safety gains — and that the workplace-safety case for paid sick leave may be much narrower than cross-sectional evidence implies.

That is the pitch. Cleaner, more causal, more honest about external validity, and more obviously about the world rather than the estimator.

---

## 2. CONTRIBUTION CLARITY

**Contribution in one sentence:**  
The paper provides what it presents as the first quasi-experimental evidence on whether paid sick leave mandates reduce workplace injuries, and finds no measurable effect in the large-establishment OSHA sample.

### Is this contribution clearly differentiated from the closest 3–4 papers?
Somewhat, but not enough. The paper distinguishes itself from:
- the cross-sectional occupational-health paper by **Asfaw, Pana-Cryan, and Rosa (2012)**;
- causal paid sick leave papers focused on contagion/public health, e.g. **Pichler and Ziebarth (2020)** and **Stearns and White (2018/2015 depending citation)**;
- labor-market effects papers such as **DeAngelis et al. (2023)**.

But the introduction still sounds a bit like “take a policy that has been studied elsewhere and run a DiD on a new outcome.” That is not yet an AER-level contribution statement. The sharper distinction is not “no one has used this estimator/outcome combination,” but “a major rationale for PSL policy is workplace safety, and the best causal evidence says that rationale may not be operative where mandates actually bind least — and perhaps only where we lack data.”

### Is the contribution framed as answering a question about the WORLD, or filling a gap in a LITERATURE?
It starts with the world question, which is good: do PSL mandates reduce injuries? But it drifts too quickly into literature-gap language: first causal test, contributes to literatures, uses OSHA data, etc. The stronger frame is world-first: **Do workers getting the right to paid sick leave actually become less likely to get hurt?**

### Could a smart economist who reads the introduction explain to a colleague what’s new?
Yes, but only in a middling way: “It’s a staggered DiD on paid sick leave and workplace injuries using OSHA data, and they mostly find null effects.” That is competent, but not memorable.

What you want them to say is:  
**“There’s a common claim that sick leave laws improve workplace safety by reducing presenteeism. This paper is the first causal test I’ve seen, and for the large firms in OSHA data the answer is basically no.”**

### What would make this contribution bigger?
Several possibilities:

1. **Leaner and more explicit external-validity framing.**  
   The paper’s real result is about large establishments. It should own that. “Mandates do not reduce injuries where preexisting coverage is already high” is more precise and more credible than broad claims about mandates in general.

2. **Better connection to policy incidence / bindingness.**  
   The paper hints that the laws likely do not bind in this sample. That should be central, not a caveat. If the paper can show descriptively that treated sectors/firms in ITA already had high PSL coverage, the contribution becomes: **mandates may generate little safety benefit when they operate mainly on inframarginal employers.**

3. **Stronger mechanism evidence.**  
   The hazard-industry split is directionally right but thin. A bigger paper would trace where presenteeism should matter most: occupations with physical coordination risk, medication/fatigue sensitivity, or short-notice staffing constraints. Right now the mechanism test is too blunt to elevate the paper.

4. **More policy-relevant comparison.**  
   The ambitious question is not just “do injuries fall?” but “which margins do PSL mandates move?” A stronger paper would juxtapose safety effects against contagion/public-health effects and worker-retention effects, clarifying where the policy matters and where it does not.

In short: the paper is better if it becomes a paper about **the limits of the workplace-safety rationale for PSL mandates**, not merely a new null estimate.

---

## 3. LITERATURE POSITIONING

### Closest neighbors
The closest neighbors appear to be:

1. **Asfaw, Pana-Cryan, and Rosa (2012)** — cross-sectional relationship between paid sick leave and occupational injuries.
2. **Pichler and Ziebarth (2020)** — PSL and disease spread / public health consequences.
3. **Stearns and White** — PSL and health-related outcomes / health care utilization / disease transmission depending exact paper cited.
4. **DeAngelis et al. (2023)** — PSL and labor-market outcomes such as retention/turnover.
5. More broadly, workplace safety determinants papers such as **Morantz (2013)** and **Levine, Toffel, and Johnson (2012)**.

### How should the paper position itself relative to them?
Primarily **build on and reinterpret**, not attack.

- Relative to **Asfaw et al.**, the right move is: “their result established an important stylized fact, but because benefit provision is endogenous, policy variation is needed to assess whether the safety channel is causal.” Not “they were wrong,” but “their estimate combined treatment and selection.”
- Relative to the PSL literature, the paper should say: “existing causal work shows public-health and labor-market consequences; this paper asks whether one frequently cited additional margin — workplace safety — is real.”
- Relative to workplace-safety papers, it should say: “benefit mandates are a conceptually distinct determinant from regulation, enforcement, or unions.”

### Is it currently positioned too narrowly or too broadly?
A bit of both, oddly.

- **Too broadly** in claiming to answer whether PSL mandates reduce injuries, full stop.
- **Too narrowly** in speaking mostly to the PSL-policy literature and occupational health, when the bigger conversation is about **the incidence of labor standards, the importance of bindingness, and the danger of extrapolating from cross-sectional workplace-benefit correlations**.

### What literature does the paper seem unaware of?
It should speak more directly to:
- **labor standards / mandates** literature on bindingness and pass-through;
- **frictions and worker absence / attendance behavior** literature;
- **personnel economics / job amenities** literature, especially endogenous sorting into better employers;
- the broader literature on **external validity of mandate effects across firm size and baseline compliance**.

The paper already says “large firms likely already offered sick leave,” but that insight belongs in dialogue with labor-standards economics, not just as a data limitation.

### Is the paper having the right conversation?
Not quite. The current conversation is: “here is another outcome of PSL mandates.” The more impactful conversation is:  
**“Which rationales for labor mandates survive causal scrutiny, and how does employer selection distort cross-sectional evidence about benefits and safety?”**

That is the conversation top journals care about.

---

## 4. NARRATIVE ARC

### Setup
Paid sick leave mandates are increasingly common, and one prominent rationale is that they reduce workplace injuries by discouraging sick workers from showing up to hazardous jobs. A well-cited cross-sectional paper suggests the effect could be large.

### Tension
But workplaces that offer paid sick leave are not random; they are also likely to be safer along many other dimensions. So the core policy rationale may rest on selection rather than causation. Further, the workers most affected by mandates may be in smaller firms, while the available injury data mostly cover larger firms.

### Resolution
Using staggered state mandates and OSHA data, the paper finds no detectable reduction in workplace injuries, including more severe injuries, and no stronger effects in more hazardous industries.

### Implications
The workplace-safety justification for PSL mandates appears weak in the large-firm sector observed here; the broader case for PSL likely runs more through contagion, worker welfare, or retention than through injury prevention. More generally, cross-sectional correlations between employer-provided benefits and workplace safety may be deeply misleading.

### Does the paper have a clear narrative arc?
It has the ingredients, but they are not yet ordered for maximum force. At present it reads somewhat like a competent policy evaluation with a pile of estimators and null results. The story is there, but the paper does not fully commit to it.

The story it **should** tell is:

1. Policymakers often justify PSL by claiming it reduces on-the-job injuries.
2. The evidence behind that claim is observational and highly vulnerable to selection.
3. This paper brings policy variation to bear and finds no evidence of injury reductions in the large-firm sector.
4. Therefore, either the presenteeism channel is weaker than assumed, or it operates only where the mandate actually changes coverage — likely outside the observed sample.
5. That shifts both the policy debate and the research agenda.

That is a coherent arc. Right now, the paper spends too much energy proving diligence and not enough energy clarifying what belief the reader should update.

---

## 5. THE “SO WHAT?” TEST

### What fact would I lead with at a dinner party of economists?
“People often argue that paid sick leave laws make workplaces safer because sick workers stay home. This paper says that in the large-firm OSHA data, injury rates don’t fall after those mandates.”

That is reasonably interesting. It is not electric, but it is a real policy claim being tested.

### Would people lean in or reach for their phones?
Some would lean in — especially labor, public, and health economists — but many would ask almost immediately: **“Do the laws bind in this sample?”** That is exactly the right question, and it is currently also the paper’s biggest weakness.

### What follow-up question would they ask?
Likely one of these:
- “Aren’t these mostly large employers that already had paid sick leave?”
- “So is the null informative about the policy, or just about the sample?”
- “Can you show anything about where coverage actually changed?”
- “Does this mean the injury rationale is wrong, or just that these mandates were inframarginal?”

Those questions are not fatal, but the paper needs to answer them in the framing, not wait for the discussion section.

### If the findings are null or modest: is the null itself interesting?
Yes — but only conditionally. Nulls are publishable when they overturn a widely cited policy rationale or expose an important mismatch between policy claims and actual margins of treatment. This paper is close to that, but it has not yet fully made the case.

Right now it risks feeling like: “we didn’t detect an effect in noisy data on a sample that may not be treated much.”  
The paper needs to become: **“the prominent workplace-safety rationale for PSL is not supported in the sector where we can causally test it, and that is informative because it reveals how much prior evidence likely reflected employer selection.”**

That is a meaningful null.

---

## 6. STRUCTURAL SUGGESTIONS

### What would make it read better?

1. **Shorten the estimator parade in the introduction and main results.**  
   The introduction devotes too much prime real estate to Callaway-Sant’Anna, Sun-Abraham, TWFE, wild bootstrap, etc. That is not what gets a paper into AER. One preferred design plus a sentence on corroboration is enough up front.

2. **Move more inferential detail out of the way.**  
   The discussion of minimum detectable effects, Bacon decomposition, and some of the estimator-to-estimator comparisons can be shortened or pushed back. For an editorial audience, these are not the headline.

3. **Front-load the sample limitation.**  
   The single most important interpretive fact — that OSHA ITA disproportionately covers larger establishments likely already offering PSL — appears too late. It should appear in the abstract, introduction, and perhaps even title/subtitle logic.

4. **Tighten the literature-contribution paragraph.**  
   The current “these findings contribute to several literatures” paragraph is standard seminar prose. It weakens momentum. Replace with a sharper statement about which belief is being revised.

5. **Rework the heterogeneity section.**  
   Right now it feels like an expected add-on. Either make it central as mechanism evidence or compress it. As written, it does not carry enough weight to justify much space.

6. **Conclusion should do more than summarize.**  
   The conclusion should explicitly tell the reader how to reinterpret the welfare case for PSL mandates and what kind of future evidence would settle the small-firm question. Right now it mostly restates the findings.

### Is the paper front-loaded with the good stuff?
Reasonably, yes, but not enough. The key insight is in the introduction, but the most important caveat/interpretive lens is buried. The reader should know by page 2 that this is a paper about **causal evidence in a sample of mostly large firms**.

### Are there results buried in robustness that should be in the main results?
Possibly not as “results,” but the placebo and the COVID exclusion are less important than the sample-bindingness issue. What is missing from the main text is not another robustness table; it is a main-text descriptive treatment-intensity argument.

### Is the conclusion adding value or just summarizing?
Mostly summarizing. It should make a stronger conceptual point.

---

## 7. WHAT WOULD MAKE THIS AN AER PAPER?

At the moment, this is **not** an AER paper. It is competent, coherent, and potentially field-journal quality, but it is too limited and too cautious in ambition.

### What is the gap?

#### 1. Framing problem
Yes. The science may be fine, but the story is underpowered. The paper should be framed as testing a major policy rationale, not as filling an outcome gap in the PSL literature.

#### 2. Scope problem
Definitely. The paper’s central limitation — large-firm OSHA coverage — cuts directly against the policy object of interest. That does not kill the paper, but it makes the current contribution narrower than the title and intro imply.

#### 3. Novelty problem
Moderate. The exact question may be new, but the format is familiar: staggered policy adoption, administrative outcome, null result. For AER, novelty must come from the importance of the question and the sharpness of the lesson, not the technique.

#### 4. Ambition problem
Yes. The paper is too safe. It shows care, but not enough conceptual reach. The most interesting interpretation — that the apparent safety benefits of employer-provided leave may largely reflect sorting and that mandates may be inframarginal where compliance is already high — is treated as a caveat rather than the main thesis.

### Single most impactful piece of advice
**Reframe the paper around bindingness and the limits of the workplace-safety rationale for paid sick leave mandates: make the central claim “mandates do not reduce injuries where coverage was already high,” not the overbroad “mandates do not reduce injuries.”**

That one change would improve the honesty, credibility, and importance of the paper simultaneously. It would also help the paper speak to a broader economics audience interested in labor standards, incidence, and treatment intensity.

---

### Strategic Assessment

- **Current framing quality:** Adequate
- **Contribution clarity:** Somewhat fuzzy
- **Literature positioning:** Could be stronger
- **Narrative arc:** Serviceable
- **AER distance:** Medium-Far
- **Single biggest improvement:** Recast the paper as evidence on the limited safety effects of sick-leave mandates in a largely already-covered large-firm sector, and use that to challenge the broader workplace-safety rationale for the policy.